Physician profile
Medeia E Gartel
NPI 1447243241
$1,435.10
in general payments reported to CMS, 2019-2025
10 companies · $44.14 in 2025
The $44.14 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $241 · 2021: $125 · 2022: $206 · 2023: $117 · 2025: $44.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $729.22 | 2019-2023 | Invega Sustenna, Invega Trinza |
| Allergan, INC. | $204.24 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $138.82 | 2019-2025 | Abilify Asimtufii, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $99.42 | 2019-2020 | |
| Lundbeck LLC | $78.10 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.64 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $56.09 | 2019 | |
| Neurocrine Biosciences, INC. | $39.31 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $13.44 | 2019 | |
| Indivior INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medeia Gartel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.